Importantly, although treatment with S-NO-AAT reduced RMA cell viability, it did not alter the overall size of tumor cell population, suggesting that in vivo inhibition of tumor development by hAAT requires factors beyond high NO levels. The gene discussed is SERPINA1; the disease is neoplasm.